DBPR108 Tablets in Type 2 Diabetes Mellitus Patients

Condition:   Type 2 Diabetes Mellitus Interventions:   Drug: 50mg group;   Drug: 100mg group;   Drug: 200mg group;   Drug: placebo group Sponsor:   CSPC ZhongQi Pharmaceutical Technology Co., Ltd. Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials